Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol.
暂无分享,去创建一个
[1] M. Lohse,et al. GS Activation Is Time-limiting in Initiating Receptor-mediated Signaling* , 2006, Journal of Biological Chemistry.
[2] L. Lazzeroni,et al. A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure , 2006 .
[3] D. Cooper,et al. A Specific Pattern of Phosphodiesterases Controls the cAMP Signals Generated by Different Gs-Coupled Receptors in Adult Rat Ventricular Myocytes , 2006, Circulation research.
[4] P. Wolf,et al. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.
[5] M. Lohse,et al. Dynamics of receptor/G protein coupling in living cells , 2005, The EMBO journal.
[6] H. Bruck,et al. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. , 2005, Journal of the American College of Cardiology.
[7] M. Lohse,et al. Molecular basis of inverse agonism in a G protein–coupled receptor , 2005, Nature chemical biology.
[8] Julie A. Johnson,et al. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy. , 2005, Pharmacogenetics and genomics.
[9] Mark H Ellisman,et al. A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells , 2005, Nature Methods.
[10] Michel Bouvier,et al. Real-time monitoring of receptor and G-protein interactions in living cells , 2005, Nature Methods.
[11] K. Lorenz,et al. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy , 2004, Nature Medicine.
[12] Martin J. Lohse,et al. Novel Single Chain cAMP Sensors for Receptor-induced Signal Propagation*♦ , 2004, Journal of Biological Chemistry.
[13] R. Lefkowitz,et al. Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. , 2004, The Journal of clinical investigation.
[14] W. Colledge,et al. Markedly reduced effects of (−)‐isoprenaline but not of (−)‐CGP12177 and unchanged affinity of β‐blockers at Gly389‐β1‐adrenoceptors compared to Arg389‐β1‐adrenoceptors , 2004 .
[15] Mark A Rizzo,et al. An improved cyan fluorescent protein variant useful for FRET , 2004, Nature Biotechnology.
[16] M. Lohse. β-Adrenoceptor polymorphisms and heart failure , 2004 .
[17] M. Lohse,et al. Gi protein activation in intact cells involves subunit rearrangement rather than dissociation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Liggett,et al. Pharmacology and physiology of human adrenergic receptor polymorphisms. , 2003, Annual review of pharmacology and toxicology.
[19] Martin J. Lohse,et al. What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure? , 2003, Circulation research.
[20] Zhaoqian Liu,et al. Gly389Arg polymorphism of β1‐adrenergic receptor is associated with the cardiovascular response to metoprolol , 2003, Clinical pharmacology and therapeutics.
[21] C. Stein,et al. The Gly389Arg β1‐adrenergic receptor polymorphism: A predictor of response to β‐blocker treatment? , 2003 .
[22] G. Dorn,et al. β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure , 2003, Nature Medicine.
[23] I. Zineh,et al. β1‐Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol , 2003, Clinical pharmacology and therapeutics.
[24] M. Lohse,et al. Measurement of the millisecond activation switch of G protein–coupled receptors in living cells , 2003, Nature Biotechnology.
[25] U. B. Nair,et al. A common β1‐adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β‐blockade , 2003 .
[26] M. Bristow. Antiadrenergic therapy of chronic heart failure: surprises and new opportunities. , 2003, Circulation.
[27] S. Kardia,et al. Synergistic polymorphisms of the β1- and α2c-adrenergic receptors and the risk of congestive heart failure ☆ , 2003 .
[28] A. Miyawaki. Visualization of the spatial and temporal dynamics of intracellular signaling. , 2003, Developmental cell.
[29] S. Kardia,et al. Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure , 2002 .
[30] K. Fong,et al. Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro. , 2002, Journal of the American College of Cardiology.
[31] Robert J. Lefkowitz,et al. Seven-transmembrane-spanning receptors and heart function , 2002, Nature.
[32] S. Ikeda,et al. Functional expression and FRET analysis of green fluorescent proteins fused to G‐protein subunits in rat sympathetic neurons , 2001, The Journal of physiology.
[33] M. Lohse,et al. Constitutive Activity of the Human β1-Adrenergic Receptor in β1-Receptor Transgenic Mice , 2001 .
[34] L. Groop,et al. Polymorphism in the &bgr;1-Adrenergic Receptor Gene and Hypertension , 2001, Circulation.
[35] P. Schnabel,et al. Characterization of β1‐selectivity, adrenoceptor‐Gs‐protein interaction and inverse agonism of nebivolol in human myocardium , 2001, British journal of pharmacology.
[36] B. Fu,et al. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. , 2000, Clinical science.
[37] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[38] M. Flesch,et al. Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium , 2000, British journal of pharmacology.
[39] M. Michel,et al. Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.
[40] M. Lohse,et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Chemtob,et al. Inverse agonist activities of β‐adrenoceptor antagonists in rat myocardium , 1999 .
[42] D. A. Mason,et al. A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor* , 1999, The Journal of Biological Chemistry.
[43] S. Ball,et al. Common polymorphisms of β1-adrenoceptor: identification and rapid screening assay , 1999, The Lancet.
[44] R Y Tsien,et al. Specific covalent labeling of recombinant protein molecules inside live cells. , 1998, Science.
[45] B. Fredholm,et al. Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[46] E. Lakatta,et al. Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling. , 1997, The American journal of physiology.
[47] S. Liggett,et al. Chimeric Mutagenesis of Putative G-protein Coupling Domains of the α2A-Adrenergic Receptor , 1996, The Journal of Biological Chemistry.
[48] M. Caron,et al. Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.
[49] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[50] J. Melnick,et al. Au-antigen particles. , 1970, The Lancet.
[51] J. S. Stephenson,et al. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). , 1962, Lancet.
[52] Stepan Gambaryan,et al. Fluorescent sensors for rapid monitoring of intracellular cGMP , 2005, Nature Methods.
[53] T. Hynes,et al. Cellular Localization of GFP-Tagged α Subunits , 2004 .
[54] K. Klotz,et al. Comparative pharmacology of human β-adrenergic receptor subtypes—characterization of stably transfected receptors in CHO cells , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.
[55] Th. Förster. Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .